1
Velikanova, Rimma, Wolters, Sharon, Hofstra, Hinko S, Postma, Maarten J, Boersma, Cornelis
Veröffentlicht in: Velikanova , R , Wolters , S , Hofstra , H S , Postma , M J & Boersma , C 2024 , ' Market Access Challenges and Solutions in Cell and Gene Therapy in The Netherlands ' , Journal of market access & health policy , vol. 12 , no. 3 , pp. 181-198 . https://doi.org/10.3390/jmahp12030015;
2024
Veröffentlicht in: Velikanova , R , Wolters , S , Hofstra , H S , Postma , M J & Boersma , C 2024 , ' Market Access Challenges and Solutions in Cell and Gene Therapy in The Netherlands ' , Journal of market access & health policy , vol. 12 , no. 3 , pp. 181-198 . https://doi.org/10.3390/jmahp12030015;
2024
2
Wolters, Sharon, Carpay, Johannes A., Pronk, Marja H., Zuurbier, Karin W.M., Driessen, Maurice T., Lyras, Leonidas, Postma, Maarten J.
Veröffentlicht in: Wolters , S , Carpay , J A , Pronk , M H , Zuurbier , K W M , Driessen , M T , Lyras , L & Postma , M J 2024 , ' A Dutch cost-effectiveness analysis of fremanezumab versus best supportive care in patients with chronic migraine and inadequate response to prior preventive therapy ' , BMC NEUROLOGY , vol. 24 , no. 1 , 214 . https://doi.org/10.1186/s12883-024-03697-x;
2024
Veröffentlicht in: Wolters , S , Carpay , J A , Pronk , M H , Zuurbier , K W M , Driessen , M T , Lyras , L & Postma , M J 2024 , ' A Dutch cost-effectiveness analysis of fremanezumab versus best supportive care in patients with chronic migraine and inadequate response to prior preventive therapy ' , BMC NEUROLOGY , vol. 24 , no. 1 , 214 . https://doi.org/10.1186/s12883-024-03697-x;
2024
3
4